1. Home
  2. CELU vs KLXE Comparison

CELU vs KLXE Comparison

Compare CELU & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • KLXE
  • Stock Information
  • Founded
  • CELU 2016
  • KLXE 2018
  • Country
  • CELU United States
  • KLXE United States
  • Employees
  • CELU N/A
  • KLXE N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • CELU Health Care
  • KLXE Energy
  • Exchange
  • CELU Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • CELU 42.2M
  • KLXE 35.8M
  • IPO Year
  • CELU N/A
  • KLXE N/A
  • Fundamental
  • Price
  • CELU $3.24
  • KLXE $1.71
  • Analyst Decision
  • CELU
  • KLXE
  • Analyst Count
  • CELU 0
  • KLXE 0
  • Target Price
  • CELU N/A
  • KLXE N/A
  • AVG Volume (30 Days)
  • CELU 586.5K
  • KLXE 161.5K
  • Earning Date
  • CELU 05-08-2025
  • KLXE 08-06-2025
  • Dividend Yield
  • CELU N/A
  • KLXE N/A
  • EPS Growth
  • CELU N/A
  • KLXE N/A
  • EPS
  • CELU N/A
  • KLXE N/A
  • Revenue
  • CELU $54,220,000.00
  • KLXE $667,400,000.00
  • Revenue This Year
  • CELU $23.29
  • KLXE N/A
  • Revenue Next Year
  • CELU N/A
  • KLXE $3.97
  • P/E Ratio
  • CELU N/A
  • KLXE N/A
  • Revenue Growth
  • CELU 138.11
  • KLXE N/A
  • 52 Week Low
  • CELU $1.00
  • KLXE $1.46
  • 52 Week High
  • CELU $5.22
  • KLXE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • CELU 59.84
  • KLXE 44.82
  • Support Level
  • CELU $3.16
  • KLXE $1.51
  • Resistance Level
  • CELU $3.40
  • KLXE $2.00
  • Average True Range (ATR)
  • CELU 0.34
  • KLXE 0.14
  • MACD
  • CELU -0.03
  • KLXE -0.02
  • Stochastic Oscillator
  • CELU 20.71
  • KLXE 35.09

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: